Vitamin D and Omega-3 Trial to Prevent and Treat Diabetic Kidney Disease [ANCILLARY OF 700049031]
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 May 2016
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Acronyms VITAL-DKD
- 07 Jun 2017 Biomarkers information updated
- 13 May 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2017.
- 26 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.